Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
Prenetics Global Limited announced strong Q1 2026 financial results with total revenue of $36 million, driven by the IM8 premium health brand's 23.1% sequential growth to $33.8 million. IM8's May 2026 monthly revenue hit a record $16.7 million, implying an annualized recurring revenue of approximately $200 million. The company raised its full-year …